Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Oncologist

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1634/theoncologist.2016-0239PMID 27789777PMCID PMC5313276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence

  2017cited by this paper
• Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

  2015cited by this paper
• Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?

  2015cited by this paper
• The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.

  2015cited by this paper
• N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer

  2015cited by this paper
• Necessity of Harvesting At Least 25 Lymph Nodes in Patients With Stage N2–N3 Resectable Gastric Cancer

  2015cited by this paper
• A Comparison of Five Competing Lymph Node Staging Schemes in a Cohort of Resectable Gastric Cancer Patients

  2014cited by this paper
• Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.

  2013cited by this paper
• Prognostic Impact of Lymph Node Retrieval and Ratio in Gastric Cancer: a U.S. Single Center Experience

  2013cited by this paper
• How many lymph nodes should be assessed in patients with gastric cancer? A systematic review

  2012cited by this paper
• A meta-analysis of D1 versus D2 lymph node dissection

  2012cited by this paper
• National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology

  2012cited by this paper
• Comparison of a Lymph Node Ratio–Based Staging System With the 7th AJCC System for Gastric Cancer: Analysis of 18,043 Patients From the SEER Database

  2012cited by this paper
• Japanese gastric cancer treatment guidelines 2010 (ver. 3)

  2011cited by this paper
• To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting.

  2010cited by this paper
• Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

  2010cited by this paper
• The Ratio Between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Regardless of the Type of Lymphadenectomy: Results From an Italian Multicentric Study in 1853 Patients

  2007cited by this paper
• Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage

  2007influential reference
• Nodal dissection for patients with gastric cancer: a randomised controlled trial.

  2006cited by this paper
• Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

  2005cited by this paper
• Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

  2004cited by this paper
• The survival of stage III gastric cancer patients is affected by the number of lymph nodes removed.

  2003cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction

  2002cited by this paper
• Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial

  2001cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients

  2000cited by this paper
• Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

  1999cited by this paper
• Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

  1998cited by this paper
• Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer

  1991cited by this paper
• Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma

  1988cited by this paper

• Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)

  2025cites this paper
• The Association between the Number of Retrieved Lymph Nodes and Survival in Gastric Cancer Surgery: A Dutch Population-Based Study

  2025cites this paper
• Robotic single-port versus multi-port distal gastrectomy for gastric cancer: a comparative analysis of the da Vinci™ SP and Xi systems

  2025cites this paper
• R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure

  2025cites this paper
• The impact of the number of lymph nodes removed with D2 lymph node dissection on survival in gastric cancer

  2025cites this paper
• Textbook outcome of gastric cancer surgery and lymph node evaluation as its parameter to improve long-term survival

  2025cites this paper
• Influence of lymphadenectomy extent on the efficacy of immunotherapy in recurrent gastric cancer patients.

  2025cites this paper
• Examining more than 35 lymph nodes improves the staging and survival in resectable advanced gastric cancer: a multi-institutional study in China

  2025cites this paper
• Patterns of Recurrence after D2 Radical Surgery for Gastric Cancer: Implications for Postoperative Radiotherapy.

  2025cites this paper
• The impact of lymph node dissection on stage I ovarian endometrioid carcinoma: A US-China Comparative Analysis

  2025cites this paper
• Comparison of a submucosal and subserosal approach in ICG-guided laparoscopic lymphadenectomy in gastric cancer patients: long-term outcomes of a phase 3 randomized clinical trial

  2025cites this paper
• Esophagojejunostomy using a circular stapler vs. a linear stapler for gastric cardia cancer patients: impact of upper margin length and tumor size on the survival rate

  2024cites this paper
• Prognostic impact of lymphovascular invasion in node-negative gastric cancer: a retrospective cohort study

  2024cites this paper
• Indocyanine green and near-infrared fluorescence-guided surgery for gastric cancer: a narrative review

  2024cites this paper
• A comprehensive overview of gastric cancer management from a surgical point of view

  2024cites this paper
• Factors influencing lymph node yield in head and neck squamous cell carcinoma: A scoping review.

  2024cites this paper
• Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: a real-world study

  2024cites this paper
• Complete mesogastric excision for gastric cancer: is it the future of gastric cancer surgery?

  2023cites this paper
• Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues

  2023cites this paper
• Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach

  2023cites this paper
• Surgeon proficiency gain and survival after gastrectomy for gastric adenocarcinoma: A population-based cohort study.

  2023cites this paper
• A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions

  2023cites this paper
• Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new?

  2023cites this paper
• Impact of Minimally Invasive Approach on Attainment of a Textbook Oncologic Outcome Following Gastrectomy for Gastric Cancer: A Review of the National Cancer Database

  2023cites this paper
• A nomogram model based on the number of examined lymph nodes–related signature to predict prognosis and guide clinical therapy in gastric cancer

  2022cites this paper
• Impact of Textbook Oncologic Outcome Attainment on Survival After Gastrectomy: A Review of the National Cancer Database

  2022cites this paper
• Safety and Efficacy of Laparoscopic Versus Open Gastrectomy in Patients With Advanced Gastric Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis

  2021cites this paper
• The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma

  2021cites this paper
• Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients

  2021cites this paper
• Retrospective Evaluation of Factors Affecting Lymph Node Retrieval Following Gastrectomies with Oncologic Intent

  2021cites this paper
• Clinical Significance of Metastasis or Micrometastasis to the Lymph Node Along Superior Mesenteric Vein in Gastric Carcinoma: a Retrospective Analysis

  2021cites this paper
• Comparison of a Tumor-Ratio–Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer

  2021cites this paper
• Clinical Significance of Metastasis or Micrometastasis to the Lymph Node Along the Superior Mesenteric Vein in Gastric Carcinoma: A Retrospective Analysis

  2021cites this paper
• Lymph node micrometastasis of poorly differentiated node-negative gastric cancer risks a worse-than-expected survival outcome under standard management algorithm.

  2021cites this paper
• Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery

  2020cites this paper
• Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.

  2020cites this paper
• Intraoperative Surrogate Indicators of Gastric Cancer Patients’ Long-Term Prognosis: The Number of Lymph Nodes Examined Relates to the Lymph Node Noncompliance Rate

  2020cites this paper
• Proposal of a novel subclassification of pN3b for improvement the prognostic discrimination ability of gastric cancer patients.

  2020cites this paper
• Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy

  2020cites this paper
• Grossing of Gastrointestinal Specimens: Best Practices and Current Controversies.

  2020cites this paper
• Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies.

  2020cites this paper
• The development and external validation of a nomogram predicting overall survival for gastric cancer patients with inadequate lymph nodes based on an international database

  2020cites this paper
• Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response

  2019cites this paper
• Relationship between microRNA-27a and efficacy of neoadjuvant chemotherapy in gastric cancer and its mechanism in gastric cancer cell growth and metastasis

  2019cites this paper
• Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation

  2019cites this paper
• The development and external validation of a nomogram predicting overall survival of gastric cancer patients with inadequate lymph nodes based on an international database

  2019cites this paper
• The relationship between the number of examined lymph nodes and the efficacy of chemotherapy for gastric cancer

  2019cites this paper
• Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.

  2019cites this paper
• Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan

  2019cites this paper
• The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of locally advanced disease.

  2018cites this paper
• A multimodality approach to improve oesophageal and gastric cancer treatment

  2018cites this paper
• Surgical treatment of gastric cancer

  2018cites this paper
• Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery

  2018cites this paper
• Assessment of the 8th edition of TNM staging system for gastric cancer: the results from the SEER and a single-institution database.

  2018cites this paper
• Surgical and Long-Term Survival Outcomes After Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis

  2018cites this paper
• The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma

  2018cites this paper
• Optimal management of resected gastric cancer

  2018cites this paper
• Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer

  2018cites this paper
• Should surgical ex vivo lymphadenectomy be a standard procedure in the management of patients with gastric cancer?

  2018cites this paper
• Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era—A Single Institute Experience over a Decade

  2018cites this paper
• The retrieval of at least 25 lymph nodes should be essential for advanced gastric cancer patients with lymph node metastasis: A retrospective analysis of single-institution database study design: Cohort study.

  2017cites this paper
• Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better?

  2017cites this paper
• Survival Analysis with Extended Lymphadenectomy for Gastric Cancer: Removing Stage Migration from the Equation

  2017cites this paper
• A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification.

  2017cites this paper